Vascular catheter-related complications in newborns

Journal of Paediatrics and Child Health

Volumn 48, Issue 2, 2012, Pages

  Wu, Jinlin ^a   Mu, Dezhi ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

complication; neonate; NICU; vascular catheter

Indexed keywords

AIR EMBOLISM; BLEEDING; CATHETER COMPLICATION; CATHETER INFECTION; CATHETER OCCLUSION; CATHETER THROMBOSIS; HEART ARRHYTHMIA; HUMAN; INTRAVASCULAR CATHETER; NEWBORN; PHLEBITIS; PRIORITY JOURNAL; REVIEW; VASOSPASM;

CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CATHETERIZATION, PERIPHERAL; CATHETERS; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; PHLEBITIS; THROMBOSIS;

EID: 84863165297     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2010.01934.x     Document Type: Review

References (52)

1. Cartwright DW,. Central venous lines in neonates: a study of 2186 catheters. Arch. Dis. Child Fetal Neonatal Ed. 2004; 89: 504-8.
2. Perlman SE, Saiman L, Larson EL,. Risk factors for late onset health care-associated blood stream infections in patients in neonatal intensive care units. Am. J. Infect. Control. 2007; 35: 177-82. (Pubitemid 46551322)
3. Aly H, Herson V, Duncan A, et al,. Is bloodstream infection peventable among premature infants? A tale of two cities. Pediatrics 2005; 115: 1513-8. (Pubitemid 43843158)
4. Gaynes RP, Edwards JR, Jarvis WR, Culver DH, Tolson JS, Martone WJ,. Nosocomial infections among neonates in high-risk nurseries in the United States. National Nosocomial Infections Surveillance System. Pediatrics 1996; 98 (3 Pt 1): 357-61. (Pubitemid 26295834)
5. Gellert GA, Ewert DP, Bendana N, et al,. A cluster of coagulase-negative staphylococcal bacteremias associated with peripheral vascular catheter colonization in a neonatal intensive care unit. Am. J. Infect. Control. 1993; 21: 16-20. (Pubitemid 23098891)
6. Freeman J, Goldmann DA, Smith NE, Sidebottom DG, Epstein MF, Platt R,. Association of intravenous lipid emulsion and coagulase-negative staphylococcal bacteremia in neonatal intensive care units. N. Engl. J. Med. 1990; 323: 301-8. (Pubitemid 20237095)
7. Patrick CC,. Coagulase-negative staphylococci: pathogens with increasing clinical significance. J. Pediatr. 1990; 116: 497-507. (Pubitemid 20124142)
8. Maayan-Metzger A, Linder N, Marom D, Vishne T, Ashkenazi S, Sirota L,. Clinical and laboratory impact of coagulasenegative staphylococci bacteremia in preterm infants. Acta. Paediatr. 2000; 89: 690-3. (Pubitemid 30624914)
9. Edwards JR, Peterson KD, Andrus ML, et al,. National Healthcare Safety Network (NHSN) report, data summary for 2006, issued June 2007. Am. J. Infect. Control. 2007; 35: 290-301. (Pubitemid 46915458)
10. Kaufman D, Fairchild KD,. Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants. Clin. Microbiol. Rev. 2004; 17: 638-80. (Pubitemid 38970686)
11. Apostolopoulou E, Lambridou M, Lambadaridis I,. Nosocomial bloodstream infections in a neonatal intensive care unit. Br. J. Nurs. 2004; 13: 806-12.
12. Sheng WH, Wang JT, Lin MS, Chang SC,. Risk factors affecting in-hospital mortality in patients with nosocomial infections. J. Formos. Med. Assoc. 2007; 106: 110-8.
13. Dann AI,. Central line sepsis in children with gastrointestinal disorders. Gastroentreol. Nurs. 1994; 16: 259-63.
14. Garland JS, Alex CP, Sevallius JM, et al,. Cohort study of the pathogenesis and molecular epidemiology of catheter-related bloodstream infection in neonates with peripherally inserted central venous catheters. Infect. Control Hosp. Epidemiol. 2008; 29: 243-9. (Pubitemid 351269190)
15. Krediet TG, Mascini EM, van Rooij E, Vlooswijk J, Paauw A, Gerards LJ,. Molecular epidemiology of coagulase-negative staphylococci causing sepsis in a neonatal intensive care unit over an 11-year period. J. Clin. Microbiol. 2004; 42: 992-5. (Pubitemid 38332815)
16. Raimundo O, Heusslery H, Bruhn JB, et al,. Molecular epidemiology of coagulase-negative staphylococcal bacteraemia in a newborn intensive care unit. J. Hosp. Infect. 2002; 51: 33-42. (Pubitemid 37554840)
17. McNeely DF, Saint-Louis F, Noel GJ,. Neonatal enterococcal bacteremia: an increasingly frequent event with potentially untreatable pathogens. Pediatr. Infect. Dis. 1996; 15: 800-5. (Pubitemid 26304456)
18. Saiman L, Ludington E, Dawson J, et al,. Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr. Infect. Dis. 2001; 20: 1119-24. (Pubitemid 34016422)
19. Carter JE, Laurini JA, Evans TN, Estrada B,. Neonatal Candida parapsilosis meningitis and empyema related to epidural migration of a central venous catheter. Clin. Neurol. Neurosurg. 2008; 110: 614-8.
20. Fairchild KD, Tomkoria S, Sharp EC, Mena FV,. Neonatal Candida glabrata sepsis: clinical and laboratory features compared with other Candida species. Pediatr. J. Infect. Dis. 2002; 21: 39-43. (Pubitemid 34073957)
21. Chapman RL, Faix RG,. Invasive neonatal candidiasis: an overview. Semin. Perinatol. 2003; 27: 352-6. (Pubitemid 37363187)
22. Belet N, Dalgià N, Oncel S, et al,. Catheter-related fungemia caused by Saccharomyces cerevisiae in a newborn. Pediatr. Infect. Dis. 2005; 24: 1125. (Pubitemid 43011080)
23. Crnich CJ, Maki DG,. The promise of novel technology for the prevention of intravascular device-related bloodstream infection. I. Pathogenesis and short-term devices. Clin. Infect. Dis. 2002; 34: 1232-42. (Pubitemid 34450672)
24. Wardlea SP, Kelsallb AWR, Yoxallc CW, Subhedar NV,. Percutaneous femoral arterial and venous catheterisation during neonatal intensive care. Arch. Dis. Child. Fetal Neonatal. Ed. 2001; 85: F119-F122. (Pubitemid 32816617)
25. Lodha A, Furlan AD, Whyte H, Moore AM,. Prophylactic antibiotics in the prevention of catheter-associated bloodstream bacterial infection in preterm neonates: a systematic review. J. Perinatol. 2008; 28: 526-33.
26. Jardine LA, Inglis GD, Davies MW,. Prophylactic systemic antibiotics to reduce morbidity and mortality in neonates with central venous catheters. Cochrane Database Syst. Rev. 2008; 1: CD006179.
27. Austin NC, Darlow B,. Prophylactic oral antifungal agents to prevent systemic candida infection in preterm infants. Cochrane Database Syst. Rev. 2003; 4: CD003478.
28. Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Donowitz LG,. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N. Engl. J. Med. 2001; 345: 1660-6. (Pubitemid 33126821)
29. Filippi L, Pezzati M, Di Amario S, Poggi C, Pecile P,. Fusidic acid and heparin lock solution for the prevention of catheter-related bloodstream infections in critically ill neonates: a retrospective study and a prospective, randomized trial. Pediatr. Crit. Care Med. 2007; 8: 556-62. (Pubitemid 350076462)
30. Garland JS, Alex CP, Henrickson KJ, McAuliffe TL, Maki DG,. A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial. Pediatrics 2005; 116: e198-205. (Pubitemid 44161440)
31. Kuhle S, Male C, Mitchell L,. Developmental hemostasis: pro- and anticoagulant systems during childhood. Semin. Thromb. Hemost. 2003; 29: 329-37. (Pubitemid 37059761)
32. Ramasethu J,. Management of vascular thrombosis and spasm in the newborn. NeoReviews 2005; 6: e298-311.
33. Coleman MM, Spear ML, Finkelstein M, et al,. Short term use of umbilical arterial catheters may not be associated with increased incidence of thrombosis. Pediatrics 2004; 113: 770-4. (Pubitemid 38437382)
34. Monagle P, Chan A, Massicote P, Chalmers E, Michelson AD,. Antithrombotic therapy in children. The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004; 126 (Suppl. 3): S645-87.
35. Roy M, Turner-Gomes S, Gill G, Way C, Mernagh J, Schmidt B,. Accuracy of Doppler ultrasonography for the diagnosis of thrombosis associated with umbilical venous catheters. J. Pediatr. 2002; 140: 131-4. (Pubitemid 34117481)
36. Shah PS, Shah VS,. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters. Cochrane Database Syst. Rev. 2008; 2: CD002772.
37. Gupta AA, Leaker M, Andrew M, et al,. Safety and outcomes of thrombolysis with tissue plasminogen activator for treatment of intravascular thrombosis in children. J. Pediatr. 2001; 139: 682-8. (Pubitemid 33097434)
38. Svoboda P, Barton RP, Barbarash OL, et al,. Recombinant urokinase is safe and effective in restoring catheter patency to occluded central venous devices: a multicenter, international trial. Crit. Care Med. 2004; 32: 1990-6. (Pubitemid 39372530)
39. Kerner JA, Garcia-Careaga MG, Fisher AA,. Treatment of catheter occlusion in pediatric patients. JPEN J. Parenter. Enteral Nutr. 2006; 30 (Suppl. 1): S73-81. (Pubitemid 43099746)
40. Hartmann J, Hussein A, Trowitzsch E, Becker J, Hennecke KH,. Treatment of neonatal thrombus formation with recombinant tissue plasminogen activator: six years experience and review of the literature. Arch. Dis. Child. Fetal Neonatal. Ed. 2001; 85: F18-22.
41. Vasquez P, Burd A, Mehta R, Hiatt M, Hegyi T,. Resolution of peripheral artery catheter induced ischemic injury following prolonged treatment with topical nitroglycerine ointment in a newborn: a case report. J. Perinatol. 2003; 23: 348-50. (Pubitemid 36764129)
42. Baserga MC, Puri A, Sola A,. The use of topical nitroglycerine ointment to treat peripheral tissue ischemia secondary to arterial line complications in neonates. J. Perinatol. 2002; 22: 416-9.
43. Foster L, Wallis M, Paterson B, James H,. A descriptive study of peripheral intravenous catheters in patients admitted to a pediatric unit in one Australian hospital. J. Infus. Nurs. 2002; 25: 159-67.
44. Barría RM, Lorca P, Muñoz S,. Randomized controlled trial of vascular access in newborns in the neonatal intensive care unit. J. Obstet. Gynecol. Neonatal. Nurs. 2007; 36: 450-6.
45. Barrington KJ,. Umbilical artery catheters in the newborn: effects of catheter materials. Cochrane Database Syst. Rev. 2000; 2: CD000949.
46. Tripathi S, Kaushik V, Singh V,. Peripheral IVs: factors affecting complications and patency-a randomized controlled trial. J. Infus. Nurs. 2008; 31: 182-8.
47. Young T,. Wound healing in neonates. J. Wound Care 1995; 4: 285-8.
48. Banta C,. Hyaluronidase. Neonatal Netw. 1992; 11: 103-5.
49. Hruszkewycz V, Holtrop PC, Batton DG, Morden RS, Gibson P, Band JD,. Complications associated with central venous catheters inserted in critically ill neonates. Infec. Control Hosp. Epidemiol. 1991; 12: 544-8.
50. Levy I, Mosseri R, Garty B,. Peripheral intravenous infusion-another cause of air embolism. Acta Paediatr. 1996; 85: 385-6. (Pubitemid 26105075)
51. Nowlen TT, Rosenthal GL, Johnson GL, Tom DJ, Vargo TA,. Pericardial effusion and tamponade in infants with central catheters. Pediatrics 2002; 110 (1 Pt 1): 137-42. (Pubitemid 34742653)
52. Serrano M, Garcia-Alix A, Lopez JC, Pérez J, Quero J,. Retained central venous lines in the newborn: report of one case and systematic review of the literature. Neonatal Netw. 2007; 26: 105-10.